NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51662-1404-1 | 51662-1404 | HUMAN PRESCRIPTION DRUG | DOXAPRAM HYDROCHLORIDE | DOXAPRAM HYDROCHLORIDE | INJECTION | INTRAVENOUS | 20191019 | N/A | NDA | NDA014879 | HF Acquisition Co LLC, DBA HealthFirst | DOXAPRAM HYDROCHLORIDE | 20 mg/mL | 1 VIAL in 1 CARTON (51662-1404-1) / 20 mL in 1 VIAL |
0641-6018-01 | 0641-6018 | HUMAN PRESCRIPTION DRUG | Dopram | Doxapram hydrochloride | INJECTION | INTRAVENOUS | 19650623 | N/A | NDA | NDA014879 | Hikma Pharmaceuticals USA Inc. | DOXAPRAM HYDROCHLORIDE | 20 mg/mL | 20 mL in 1 VIAL (0641-6018-01) |
0641-6018-06 | 0641-6018 | HUMAN PRESCRIPTION DRUG | Dopram | Doxapram hydrochloride | INJECTION | INTRAVENOUS | 19650623 | N/A | NDA | NDA014879 | Hikma Pharmaceuticals USA Inc. | DOXAPRAM HYDROCHLORIDE | 20 mg/mL | 6 VIAL in 1 CARTON (0641-6018-06) / 20 mL in 1 VIAL (0641-6018-01) |